Industry Watch - While the megadeals that dramatically reconfigured the pharmaceuticals playing field in the past decade are noticeably absent these days, industry pros expect the sector landscape to continue to change in small ways, with less-sizable deals, as drug makers become more selective in choosing targets and start to shift their focus away from product-driven deals toward more ...
|Year of Publication:||
|Type of Publication:||Article|
|Title record from database:|| OLC-SSG Economic Sciences|
|Availability:||More access options|
|More options (other):|
|Description not available.|